Annual Drug Patent Expirations for TRICOR
Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from six suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for TRICOR.
This drug has one hundred and fifty-seven patent family members in twenty-seven countries.
The generic ingredient in TRICOR is fenofibrate. Six suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
